Kronos Bio Expands Scientific Advisory Board with Addition of Roger D. Kornberg, Ph.D.
SAN MATEO, Calif. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Kronos Bio, Inc., a Two River portfolio company, today announced the appointment of Roger…
Pharmaceuticals, Biotechnology and Life Sciences
SAN MATEO, Calif. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Kronos Bio, Inc., a Two River portfolio company, today announced the appointment of Roger…
NEW YORK–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Glenn P. Sblendorio, Chief Executive Officer and President of IVERIC…
Derek Choy recognized as a leader in facilitating intelligent HCP engagement for sales and marketing SAN FRANCISCO–(BUSINESS WIRE)–Today, Aktana, the…
SAN DIEGO–(BUSINESS WIRE)–Progenity, Inc., a privately held biotechnology company developing precision medicine solutions across genomic/epigenomic, proteomic, and microbiomic diagnostic and…
LONDON–(BUSINESS WIRE)–#Biotechnology–The global seborrheic keratosis treatment market size is poised to reach USD 634 million by 2023, according to a…
DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Contract Development and Manufacturing Market by Service (Pharmaceutical, Biologics, Active Pharma Ingredients, Tablet, Capsule, Parenteral, Oral Liquid),…
LONDON–(BUSINESS WIRE)–#Biotechnology–The global hepatitis C drugs market size is poised to decline by USD (5.71) billion during 2019-2023, according to…
Revenues of $4.3 billion GAAP diluted loss per share of $0.63 Non-GAAP diluted EPS of $0.60 Spend base reduction of…
Initiation of single, pivotal, 12-week, Phase 3 gMG clinical trial on track for the second half of 2019 Initiation of…
— Second-Quarter 2019 Net Sales of $320.6 Million Increased 6 Percent; Second-Quarter 2019 GAAP Net Loss of $5.1 Million; Adjusted…